SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062437
Filing Date
2023-11-13
Accepted
2023-11-13 07:30:28
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acst-20230930.htm   iXBRL 10-Q 2158360
2 EX-31.1 acst-ex31_1.htm EX-31.1 15265
3 EX-31.2 acst-ex31_2.htm EX-31.2 14511
4 EX-32.1 acst-ex32_1.htm EX-32.1 10651
5 EX-32.2 acst-ex32_2.htm EX-32.2 11460
6 GRAPHIC img180422703_0.jpg GRAPHIC 22519
7 GRAPHIC img180422703_1.jpg GRAPHIC 45716
8 GRAPHIC img180422703_2.jpg GRAPHIC 72607
9 GRAPHIC img180422703_3.jpg GRAPHIC 14782
10 GRAPHIC img180422703_4.jpg GRAPHIC 68654
11 GRAPHIC img180422703_5.jpg GRAPHIC 64097
12 GRAPHIC img180422703_6.jpg GRAPHIC 41281
  Complete submission text file 0000950170-23-062437.txt   7702559

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acst-20230930_pre.xml EX-101.PRE 319637
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acst-20230930_cal.xml EX-101.CAL 31692
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acst-20230930_def.xml EX-101.DEF 210600
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acst-20230930_lab.xml EX-101.LAB 413779
17 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acst-20230930.xsd EX-101.SCH 63127
71 EXTRACTED XBRL INSTANCE DOCUMENT acst-20230930_htm.xml XML 920960
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 231395107
SIC: 2834 Pharmaceutical Preparations